Analystreport

Takeda Pharmaceutical Co Ltd (NYSE: TAK) had its price target lowered by analysts at JPMorgan Chase & Co. from $31.00 to $30.00. They now have an "overweight" rating on the stock.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK)